These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22171046)

  • 1. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand.
    Ochoa-Sanchez R; Comai S; Lacoste B; Bambico FR; Dominguez-Lopez S; Spadoni G; Rivara S; Bedini A; Angeloni D; Fraschini F; Mor M; Tarzia G; Descarries L; Gobbi G
    J Neurosci; 2011 Dec; 31(50):18439-52. PubMed ID: 22171046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
    López-Canul M; Comai S; Domínguez-López S; Granados-Soto V; Gobbi G
    Eur J Pharmacol; 2015 Oct; 764():424-432. PubMed ID: 26162699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
    Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
    Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
    Comai S; Ochoa-Sanchez R; Gobbi G
    Behav Brain Res; 2013 Apr; 243():231-8. PubMed ID: 23333399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.
    Lopez-Canul M; Palazzo E; Dominguez-Lopez S; Luongo L; Lacoste B; Comai S; Angeloni D; Fraschini F; Boccella S; Spadoni G; Bedini A; Tarzia G; Maione S; Granados-Soto V; Gobbi G
    Pain; 2015 Feb; 156(2):305-317. PubMed ID: 25599452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
    Posa L; De Gregorio D; Gobbi G; Comai S
    Curr Med Chem; 2018; 25(32):3866-3882. PubMed ID: 28183259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
    Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
    ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a highly selective and potent partial agonist of the MT₂ melatonin receptor.
    Sakurai T; Koike T; Nakayama M
    Pharmacology; 2014; 93(5-6):244-52. PubMed ID: 25059758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
    Gobbi G; Comai S
    J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific melatonin receptor promotes a deeper sleep.
    Harrington M
    Lab Anim (NY); 2012 Jan; 41(2):31. PubMed ID: 22261877
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.
    Fisher SP; Sugden D
    Neurosci Lett; 2009 Jun; 457(2):93-6. PubMed ID: 19429170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability.
    Ferlenghi F; Mari M; Gobbi G; Elisi GM; Mor M; Rivara S; Vacondio F; Bartolucci S; Bedini A; Fanini F; Spadoni G
    ChemMedChem; 2021 Oct; 16(19):3071-3082. PubMed ID: 34213063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
    J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
    Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
    J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evidence for transactivation within melatonin MT
    Gerbier R; Ndiaye-Lobry D; Martinez de Morentin PB; Cecon E; Heisler LK; Delagrange P; Gbahou F; Jockers R
    FASEB J; 2021 Jan; 35(1):e21161. PubMed ID: 33156577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking melatonin  MT
    Comai S; De Gregorio D; Posa L; Ochoa-Sanchez R; Bedini A; Gobbi G
    J Pineal Res; 2020 Aug; 69(1):e12653. PubMed ID: 32239546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.